Index

Controversies in Obstetrics & Gynecology Usha Manaktala, Latika Sahu, Devender Kumar

SECTION 1: OBSTETRICS
CHAPTER 1:Controversies in Prenatal Screening for Aneuploidy
- OVERVIEW
- CONTROVERSIES
  - Selective versus Universal Screening
  - First Trimester versus Second Trimester Screening
- RISK ASSESSMENT: TWIN GESTATION
  - Nuchal Translucency in Twins
  - Nuchal Translucency Combined with Serum Markers
- NONINVASIVE PRENATAL TESTING: SCREENING OR DIAGNOSIS?
- RECOMMENDATIONS
CHAPTER 2:Prenatal Care: How Many Antenatal Visits are Required?
- INTRODUCTION
- OBJECTIVES OF A PRENATAL VISIT5
- EVOLVING MODELS OF PRENATAL CARE
- RECOMMENDATIONS BY VARIOUS ORGANIZATIONS
- CONCLUSION
CHAPTER 3:Management of Midtrimester Preterm Prelabor Rupture of the Membranes
- OVERVIEW
- INPATIENT OR OUTPATIENT MANAGEMENT
- ANTENATAL SURVEILLANCE: MATERNAL AND FETAL
- ROLE OF AMNIOCENTESIS
- ROLE OF PROPHYLACTIC ANTIBIOTIC: REGIMEN AND DURATION
  - Role of Vaginal Cleansing in Labor
- ROLE OF TOCOLYSIS
- ROLE OF CORTICOSTEROIDS
- ROLE OF AMNIOINFUSION FOR PREVENTION OF PULMONARY HYPOPLASIA
- ROLE OF FIBRIN GLUE
- TIMING OF DELIVERY
- MODE OF DELIVERY
- RECOMMENDATIONS
CHAPTER 4:Recurrent Miscarriage: The Role of Supplementation of Progesterone
- INTRODUCTION
- UNEXPLAINED RECURRENT MISCARRIAGE
  - Management
- ROLE OF PROGESTERONE IN RECURRENT MISCARRIAGE
- CONCLUSION
- CURRENT TRIALS
CHAPTER 5:Monochorionic Twins: Is Elective Preterm Delivery Mandatory?
- OVERVIEW
- SPECIFIC COMPLICATIONS OF MONOCHORIONIC TWIN PREGNANCIES
- OPTIMAL TIMING AND MODE OF DELIVERY: CONTROVERSIES
  - Uncomplicated MCDA Pregnancies (Without Fetal Growth Restriction and TTTS)
  - Monochorionic Monoamniotic (MCMA) Pregnancies
    - Conjoined Twins
    - Severe Twin-to-Twin Transfusion Syndrome
- RECOMMENDATIONS
CHAPTER 6:Pre-eclampsia: Is there a Role of Prophylaxis?
- OVERVIEW
- ETIOPATHOGENESIS
- PROPHYLAXIS IN PRE-ECLAMPSIA
  - Prevention of Development of Risk Factors
- CONTROVERSIES IN PROPHYLAXIS FOR PRE-ECLAMPSIA
- RECOMMENDATIONS
CHAPTER 7:Management of Gestational Diabetes Mellitus: Insulin or OHA or Insulin with OHA
- OVERVIEW
- MANAGEMENT—CONTROVERSIES
  - Medical Nutrition Therapy
  - Exercise
- INSULIN THERAPY
  - When to Start Insulin?
  - Types of Insulin
- DRAWBACKS OF INSULIN THERAPY: NEED OF ORAL HYPOGLYCEMIC AGENTS
  - Glyburide
  - Metformin
- OTHER ORAL HYPOGLYCEMIC AGENTS
  - Drawbacks of Oral Hypoglycemic Agents
- CONCLUSION
CHAPTER 8:Mild Hypertension in Pregnancy: Management Options
- PRETERM BIRTH
- NEONATAL OUTCOME
- ECONOMICS
- CONCLUSION
CHAPTER 9:Intrauterine Death of Fetus: Expectant Management versus Immediate Induction of Labor
- OVERVIEW
- DIAGNOSING IUFD AND DISCLOSURE TO PARENTS
- IDENTIFYING THE CAUSE OF IUFD: MATERNAL ASSESSMENT
- CONTROVERSIES
  - Management of IUFD: Expectant versus Immediate Induction of Labor
    - Immediate Induction of Labor
    - Expectant Management
  - Methods for Induction of Labor
    - Contraindications for Spontaneous Labor/Vaginal Delivery
    - Managing Labor
- LOOKING FOR THE CAUSE OF IUD AFTER EXPULSION OF THE FETUS: FETAL AND PLACENTAL ASSESSMENT
  - Fetal Autopsy
  - Fetal Karyotyping and Genetic Evaluation
- POSTDELIVERY CARE AND FOLLOW-UP
- COUNSELING FOR SUBSEQUENT PREGNANCY
- RECOMMENDATIONS
CHAPTER 10:Management of Adnexal Masses in Pregnancy
- INTRODUCTION
- DIFFERENTIAL DIAGNOSIS OF ADNEXAL MASSES
  - Evaluation
  - Management
- CONTROVERSIES IN MANAGEMENT
- RECOMMENDATIONS
SECTION 2: GYNECOLOGY
CHAPTER 11:Dysfunctional Uterine Bleeding: When to Intervene Surgically?
- OVERVIEW
- SURGICAL MANAGEMENT OF DUB
  - Dilatation (D) and Curettage (C)
  - Endometrial Ablation
- CONTROVERSIES
- RECOMMENDATIONS
CHAPTER 12:Syndromic Management: What are the Pros and Cons?
- OVERVIEW
- DRUGS FOR THE SPECIFIC ORGANISM1–3
- INPATIENT THERAPY
- TREATMENT FOR PARTNER/S
  - Rationale for Syndromic Approach
    - Importance
- SYNDROMIC MANAGEMENT: PROS
- SYNDROMIC MANAGEMENT: CONS
- CONCLUSION
CHAPTER 13:Pelvic Organ Prolapse: To Mesh or Not to Mesh?
- OVERVIEW
- CONTROVERSIES ON MESH REPAIR
- RECOMMENDATIONS
CHAPTER 14:Controversies in Polycystic Ovarian Syndrome
- OVERVIEW
- DEFINITION
- ETIOPATHOLOGY
- TREATMENT
- PCOS IN TEENAGERS/ADOLESCENTS
  - Lifestyle Modification and Weight Loss
  - Treatment of Hirsutism
- CONCLUSION
CHAPTER 15:Adenomyosis in Infertile Women: What are the Options?
- INTRODUCTION
- PATHOGENESIS
- INVESTIGATIONS
- MANAGEMENT OF ADENOMYOSIS
- MANAGEMENT OPTIONS FOR ADENOMYOSIS IN INFERTILE PATIENTS
- SURGERY
- CONCLUSION
CHAPTER 16:BRCA Gene Mutation: What to do and When?
- OVERVIEW
- CONTROVERSIAL ISSUES
  - Referral for BRCA Testing
- MUTATION DETECTION
  - Risk Reduction: Nonsurgical Preventive Options
    - Surveillance
    - Chemoprevention
  - Risk Reduction: Prophylactic Surgical Options
- RECOMMENDATIONS
CHAPTER 17:Follow-up of Borderline Ovarian Tumors
- OVERVIEW
- CONTROVERSIES
- RECOMMENDATIONS
CHAPTER 18:Neoadjuvant Chemotherapy versus Upfront Surgery for Advanced Ovarian carcinoma
- OVERVIEW
- PRINCIPLES OF PRIMARY SURGERY [NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) GUIDELINES]2
- CONTROVERSIES
  - Prospective Nonrandomized Trials
  - Prospective Randomized Phase III Trials
- RECOMMENDATIONS
CHAPTER 19:Human Papillomavirus Vaccine: Should it be a Part of Universal Immunization program in India?
- INTRODUCTION
- HUMAN PAPILLOMAVIRUS
- CONCLUSION
CHAPTER 20:Menopausal and Climacteric Symptoms: Hormone versus Nonhormonal Therapy
- OVERVIEW
- DRUGS USED IN HORMONE REPLACEMENT THERAPY
- NONHORMONAL/ALTERNATIVE THERAPY FOR CLIMACTERIC SYMPTOMS
- LIFESTYLE MODIFICATIONS DIET AND SUPPLEMENTS
  - Exercise28 (International Menopause Society Recommendations)
- PSYCHOLOGICAL HEALTH IMPROVEMENT
  - Initial Investigations and Screening
- CONTROVERSIES
- FOOD AND DRUG ADMINISTRATION CONTRAINDICATIONS TO MENOPAUSAL HORMONE THERAPY3
- ALTERNATIVES TO HORMONE REPLACEMENT THERAPY
  - Pharmacological
  - Nonpharmacological
- RECOMMENDATIONS

INDEX

TOC
Index

Chapter Notes